[1] Rippon HJ, Bishop AE. Embryonic stem cells. Cell Prolif. 2004; 37(1):23-34.[2] Solter D, Gearhart J. Putting stem cells to work. Science. 1999;283(5407):1468-1470.[3] 刘天蔚.TH-GDNF基因修饰的胚胎干细胞治疗帕金森病模型大鼠的实验研究[D].山东:青岛大学,2007:1-98.[4] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-1147.[5] 李海波.过表达野生型及帕金森病相关突变型α-synuclein对人胚胎干细胞向多巴胺能神经元分化的影响[D].湖南:中南大学, 2010:1-52.[6] 中国知网.中国学术期刊总库[DB/OL].2013-05-20. https://www.cnki.net[7] 万方数据库.万方数据知识服务平台[DB/OL].2013-05-20. http://www.wanfangdata.com.cn/ [8] 呙登俊,王绪平,陈宇,等.胶质细胞源性神经营养因子基因修饰的胚胎干细胞移植治疗血管性痴呆大鼠[J].中华移植杂志(电子版), 2012,6(4):263-268.[9] 闫晓明,李勇杰,关云谦,等.胚胎干细胞分化的神经前体细胞移植治疗帕金森病的实验研究[J].神经疾病与精神卫生,2009, 9(6): 490-492.[10] 马杰,杨敏,张重功,等.同种异体胚胎干细胞移植治疗小鼠缺氧缺血性脑损伤[J].中华急诊医学杂志,2007,16(2):158-162.[11] 杨敏,江峰,杨建华,等.胚胎干细胞来源神经前体细胞在缺氧缺血性脑损伤海马内的分化[J].上海交通大学学报(医学版),2006, 26(7): 733-737.[12] 杨建华,李长德,马杰,等.胚胎干细胞移植在中枢神经系统损伤小鼠中的应用[J].中国康复医学杂志,2005,20(8):569-571.[13] 唐军,徐海伟,吴旋,等.帕金森病大鼠模型的改进及神经前体细胞移植治疗的行为学研究[J].中国行为医学科学,2004,13(1):8-10.[14] 贡志刚.细胞移植治疗帕金森病相关实验研究[D].江苏:苏州大学, 2003:1-110.[15] 陈先文,陈生弟,刘振国,等.铁剂诱发黑质多巴胺能神经元变性[J].中华老年医学杂志,2002,21(1):44-47.[16] Brecknell JE, Dunnett SB, Fawcett JW. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience. 1995; 64(1):219-227.[17] Ogata A, Tashiro K, Nukuzuma S, et al. A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol. 1997;3(2):141-147.[18] 刘军,陈生弟,刘振国,等.黑质注射脂多糖致大鼠黑质纹状体多巴胺含量下降[J].中国临床神经科学,2002,10(2):109-111.[19] Toda H, Takahashi J, Mizoguchi A, et al. Neurons generated from adult rat hippocampal stem cells form functional glutamatergic and GABAergic synapses in vitro. Exp Neurol. 2000;165(1):66-76.[20] Auerbach JM, Eiden MV, McKay RD. Transplanted CNS stem cells form functional synapses in vivo. Eur J Neurosci. 2000; 12(5):1696-1704.[21] Lindvall O, Kokaia Z, Bengzon J, et al. Neurotrophins and brain insults. Trends Neurosci. 1994;17(11):490-496.[22] Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32(11):2682-2688.[23] Biju K, Zhou Q, Li G, et al. Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol Ther. 2010; 18(8):1536-1544.[24] Yasuda T, Mochizuki H. Use of growth factors for the treatment of Parkinson's disease. Expert Rev Neurother. 2010;10(6):915-924. [25] 张平,赵钢勇,陈凯,等.BDNF基因修饰骨髓间充质干细胞对AD大鼠认知障碍的改善[J].神经解剖学杂志,2011,27(6):642-646.[26] Yang C, Zhou L, Gao X, et al. Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation. Neurosurgery. 2011;68(3):691-704. |